Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379808 · ClinicalTrials.gov registry record · NA
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
A NA study of Coronary Heart Disease, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT00379808 is a NA study of Coronary Heart Disease that has completed, run by University of Florida. The registered enrollment target is 22 participants, below the 1,487-participant average among 19 other Coronary Heart Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00379808, a NA study of Coronary Heart Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a particular substance involved in inflammation, called leukotrienes, is involved in causing heart disease to occur or to progress.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG montelukast
Study Locations (1)
Florida
- University of Florida Family Practice Medical Group Clinic - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00379808
The ClinicalTrials.gov registry entry for NCT00379808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,487-participant average among 19 other Coronary Heart Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00379808 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00379808 about?
NCT00379808 is a clinical study titled "Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease". The purpose of this study is to determine whether a particular substance involved in inflammation, called leukotrienes, is involved in causing heart disease to occur or to progress.
What is the current status of trial NCT00379808?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2006-07. Estimated completion is 2009-08.
What conditions does trial NCT00379808 study?
This clinical trial studies the following conditions: Coronary Heart Disease.
What interventions are being tested in trial NCT00379808?
The interventions under investigation include: Placebo (DRUG), montelukast (DRUG).
Who is sponsoring clinical trial NCT00379808?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00379808 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Project 3: ACHIEVE- CHD
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
COMPLETED · NA
-
An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)
COMPLETED · NA
-
Walnut Consumption, Endothelial Function, and Biomarkers
COMPLETED · NA
-
Relationship Between the Menstrual Cycle and Heart Disease in Women
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.